MedTrace Logo

Urinary Biomarkers of the Progression of Alport Kidney Disease

NCT01705132 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2013-07-30

No results posted yet for this study

Summary

The purpose of the study is to determine if there are certain laboratory tests that can be performed to detect substances or features in a child's urine that can be used to measure the progress of Alport kidney disease and the effects of treatment. These tests and their results could be of use to measure responses to new treatments in future clinical trials.

Conditions

  • Alport Syndrome

Sponsors & Collaborators

Principal Investigators

  • Clifford E Kashtan, MD · University of Minnesota

Eligibility

Min Age
5 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-05-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01705132 on ClinicalTrials.gov